Skip to main content

Advertisement

Table 1 Comparison of demographic, clinical, and laboratory results in PMR patients with or without response to 12.5 mg daily of prednisone

From: The correct prednisone starting dose in polymyalgia rheumatica is related to body weight but not to disease severity

FEATURE RESPONDERS NON RESPONDERS p
Number 47 (78.3%) 13 (21.7%)  
Gender (women/men) 31/16 4/9 0.05
Age (years) 71.3 ± 7.1 71.5 ± 7.9 0.95
Weight (kg) 67.4 ± 11.4 78.5 ± 13.9 0.004
Disease duration (days) 90 (12-720) 86 (24-210) 0.32
Morning stiffness (minutes) 100.7 ± 85.9 89.0 ± 52.2 0.69
Fatigue 26 (55.3%) 10 (76.9%) 0.28
Fever 10 (21.3%) 3 (30%) 0.81
Weight loss 16 (34%) 2 (15.4%) 0.34
Peripheral arthritis 13 (27.7%) 4 (30.8%) 0.89
Carpal tunnel syndrome 16 (34.0%) 2 (15.4%) 0.34
RS3PE 8 (17.0%) 2 (15.4%) 0.78
Tenosynovitis 4 (8.5%) 1 (7.7%) 0.64
ESR (mm/h) 63.8 ± 25.8 62.5 ± 22.4 0.88
CRP (mg/L) 30 (1.5-180) 30 (2.5-247) 0.96